Register for our free email digests:
Celldex Therapeutics Inc.
www.celldextherapeutics.com
Latest From Celldex Therapeutics Inc.
Lupin’s Karkaria Addresses Biosimilars Pushback
Lupin's biotech president notes push-back by innovator firms against biosimilars in the US parallels that witnessed when small molecule generic competition first emerged, but remains confident that biosimilars will gain traction. The executive also sees little need for separate interchangeability studies.
Lupin’s Karkaria On Biosimilars Pushback And Interchangeability
Lupin's biotech president notes push-back by innovator firms against biosimilars in the US parallels that witnessed when small molecule generic competition first emerged, but remains confident that biosimilars will gain traction. The executive also sees little need for separate interchangeability studies.
Women In High Places: Slow Progress In Pharma
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
Pipeline Watch: Phase III Progress With Nimotuzumab, Solriamfetol, And Upadacitinib
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Company Information
- Industry
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Cancer
- Immune Disorders
- Alias(es)
- Virus Research Institute Inc.
- T Cell Sciences
- Avant Immunotherapeutics Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Celldex Therapeutics Inc.
- Senior Management
-
Anthony S Marucci, Pres. & CEO
Sam Martin, SVP, CFO
Tibor Keler, PhD, EVP, CSO
Ronald A Pepin, PhD, SVP, CBO
Richard Wright, Chief Commercial Officer
Diane C Young, MD, SVP, CMO - Contact Info
-
Celldex Therapeutics Inc.
Phone: (908) 454-7120
53 Frontage Rd.
Ste. 220
Hampton, NJ 08827
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice